Therapy News and Research

RSS
Antibody discovery could provide new treatment options for aggressive breast cancers

Antibody discovery could provide new treatment options for aggressive breast cancers

Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital™ PCR high complexity assays

Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital™ PCR high complexity assays

Disruption of glial circadian rhythms linked to Alzheimer's disease progression

Disruption of glial circadian rhythms linked to Alzheimer's disease progression

How psychedelics profoundly reshape the perception of time and consciousness

How psychedelics profoundly reshape the perception of time and consciousness

Intensive program leads to high type 2 diabetes remission in India

Intensive program leads to high type 2 diabetes remission in India

New gene-editing method can correct many disease-causing mutations in mammalian cells

New gene-editing method can correct many disease-causing mutations in mammalian cells

Smarter insulin pump systems help stabilize glucose in young patients, study reveals

Smarter insulin pump systems help stabilize glucose in young patients, study reveals

Ingestible capsule developed for the diagnosis of acute mesenteric ischemia

Ingestible capsule developed for the diagnosis of acute mesenteric ischemia

New type of immunotherapy could change the treatment plan for triple-negative breast cancer

New type of immunotherapy could change the treatment plan for triple-negative breast cancer

Rare case of pancreatic Hodgkin lymphoma is often misdiagnosed as pancreatic adenocarcinoma

Rare case of pancreatic Hodgkin lymphoma is often misdiagnosed as pancreatic adenocarcinoma

UC San Diego receives $6.2 million grant to establish REACH Center for Translational Science on Whole Person Health

UC San Diego receives $6.2 million grant to establish REACH Center for Translational Science on Whole Person Health

Repeated ketamine infusions offer no extra benefit for people hospitalized with depression

Repeated ketamine infusions offer no extra benefit for people hospitalized with depression

New drug combination shows promise in treating colorectal cancer

New drug combination shows promise in treating colorectal cancer

Rozanolixizumab prevents congenital heart block in high-risk pregnancy

Rozanolixizumab prevents congenital heart block in high-risk pregnancy

Oral targeted therapy shrinks tumors in over 70% of patients with HER2-mutant NSCLC

Oral targeted therapy shrinks tumors in over 70% of patients with HER2-mutant NSCLC

Study shows mRNA-based COVID vaccines enhance effectiveness of immune checkpoint therapy

Study shows mRNA-based COVID vaccines enhance effectiveness of immune checkpoint therapy

Infrared sauna can accelerate recovery and support performance in team-sport athletes

Infrared sauna can accelerate recovery and support performance in team-sport athletes

Epidural stimulation and physical rehabilitation can enhance recovery in spinal cord injury patients

Epidural stimulation and physical rehabilitation can enhance recovery in spinal cord injury patients

New study details how AI chatbots systematically violate ethical standards of practice

New study details how AI chatbots systematically violate ethical standards of practice

Epigenetic editing enables safer and more effective T cell therapies

Epigenetic editing enables safer and more effective T cell therapies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.